See Nutex Health's analyst price targets ($240) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$157.26
1 analysts in the last 4 months
High: $235 | Low: $235
No recommendations in the last 4 months.
Nutex Health's target price stands at $240. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
The Street's average target of $240 for NUTX implies 49.4% upside versus today's price ($157.26). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.
The history chart shows how Nutex Health's target price evolved across reporting periods, while the comparison chart places NUTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Consumer Staples, target price is commonly used to spot outliers. Nutex Health's reading of $240 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.